The Close Relationship Between Metabolic Syndrome and Hormone Receptor-Positive Early-Stage Breast Cancer
Objective: The primary aim of the current study was to investigate the frequency of metabolic syndrome (MS) in early-stage breast cancer patients. Additionally, clinicopathological factors, such as anthropometric measurements and hormonotherapy, were examined for their roles as potential confounders...
Main Authors: | Ahmet Ozveren MD, Melis Ridvanogullari Donger RD (registered dietitian), Sedat Motor MD, Gulcan Bulut MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-03-01
|
Series: | Integrative Cancer Therapies |
Online Access: | https://doi.org/10.1177/15347354231165938 |
Similar Items
-
Androgen Receptor in Hormone Receptor-Positive Breast Cancer
by: Ashfia Fatima Khan, et al.
Published: (2023-12-01) -
Interest in Integrative Medicine Among Postmenopausal Hormone Receptor–Positive Breast Cancer Patients in the EvAluate-TM Study
by: Carolin C. Hack MD, et al.
Published: (2017-06-01) -
Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women
by: Neil Carleton, BS, et al.
Published: (2022-01-01) -
Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment
by: Luka Dobovišek, et al.
Published: (2020-02-01) -
Precision Medicine in Hormone Receptor-Positive Breast Cancer
by: Azadeh Nasrazadani, et al.
Published: (2018-05-01)